Hafid Ait-Oufella
5Patents
1h-index
9Co-inventors
40Inventor score
Filing activity: Sep 30, 2008 → Jun 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9657081B2 | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases | Human Necessities | 3 | Active |
| US10948498B2 | Methods and kits for predicting the risk of having a cardiovascular disease or event | Physics | 1 | Active |
| US10556953B2 | Agent capable of depleting CD8 T cells for the treatment of myocardial infarction or acute myocardial infarction | Chemistry; Metallurgy | 0 | Active |
| US8586822B2 | Methods for producing a non human model for aortic aneurysm | Human Necessities | 0 | Active |
| US12144859B2 | B cell depleting agent for the treatment of atherosclerosis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.